JD
JDHIF.US JD Health International Inc
- Market cap
- USD 15.3B
- P/E
- 17.1x
- P/B
- 1.66x
- ROE
- 22.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is JDHIF.US undervalued?
Graham numberJDHIF.US trades 12.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
JD Health International Inc fundamental analysis
No fundamental analysis for JD Health International Inc yet.
JD Health International Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About JD Health International Inc
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and …
Full company profileJD Health International Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
JD Health International Inc annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 5.55B | 8.17B | 10.8B | 19.4B | 30.7B | 46.7B | 53.5B | 58.2B | 71.5B | 161B |
| Gross Profit | 1.38B | 1.98B | 2.81B | 4.92B | 7.20B | 9.89B | 11.9B | 13.3B | 17.7B | 42.2B |
| Operating Income | 256M | 311M | -797M | -17.1B | -857M | 803M | 631M | 1.48B | 3.70B | 12.5B |
| EBITDA | 259M | 317M | -792M | -17.0B | -832M | 944M | 858M | 5.02B | 3.98B | 13.2B |
| Net Income | 179M | 215M | -972M | -17.2B | -1.07B | 380M | 2.14B | 4.16B | 5.24B | 13.6B |
| EPS | 0.06 | 0.07 | -0.31 | -5.41 | -0.35 | 0.12 | 0.68 | 1.32 | 1.64 | 4.23 |
| Balance Sheet | ||||||||||
| Total Assets | 911M | 1.18B | 8.68B | 44.0B | 48.0B | 61.3B | 64.3B | 71.3B | 81.6B | 84.2B |
| Total Liabilities | 249M | 433M | 9.14B | 4.74B | 8.15B | 16.5B | 14.9B | 16.0B | 21.5B | 22.7B |
| Shareholders' Equity | 663M | 749M | -459M | 39.3B | 39.9B | 44.8B | 49.4B | 55.2B | 60.1B | 61.5B |
| Cash & Short-term Investments | 7.40M | 16.2M | 6.36B | 40.3B | 42.0B | 47.0B | 41.2B | 51.2B | 48.2B | 47.4B |
| Total Debt | 3.26M | 3.13M | 11.3M | 90.0M | 201M | 199M | 215M | 258M | 636M | 875M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 36.1M | 187M | 409M | 3.70B | 3.43B | 5.91B | 4.60B | 4.33B | 9.94B | 17.8B |
| Capital Expenditure | 8.62M | 2.42M | 5.69M | 38.8M | 518M | 2.27B | 69.3M | 46.4M | 151M | 362M |
| Free Cash Flow | 27.5M | 185M | 404M | 3.66B | 2.91B | 3.63B | 4.54B | 4.29B | 10.0B | 17.5B |
| Ratios | ||||||||||
| ROE | 26.9% | 28.7% | - | -43.9% | -2.7% | 0.8% | 4.3% | 7.5% | 8.7% | 22.1% |
| ROA | 19.6% | 18.2% | -11.2% | -39.2% | -2.2% | 0.6% | 3.3% | 5.8% | 6.4% | 16.1% |
| Net Profit Margin | 3.2% | 2.6% | -9.0% | -88.9% | -3.5% | 0.8% | 4.0% | 7.2% | 7.3% | 8.4% |
| Debt to Equity | 0.00x | 0.00x | - | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
JD Health International Inc dividends
JD Health International Inc has not paid dividends in the last 9 fiscal years.
Who owns JD Health International Inc
- Insiders 68.20%
- Institutions 16.98%
- Public & others 14.82%
- Shares outstanding 3.19B
- Free float 1.01B
JD Health International Inc company profile
- Company name
- JD Health International Inc
- Ticker
- JDHIF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 6,018
- Fiscal year end
- December
- Address
- Jingdong Headquarters, Beijing, China, 101111
- Website
- ir.jdhealth.com
About JD Health International Inc
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
JD Health International Inc management
3- Mr. Cao DongCEO & Director · born 1977
- Ms. Deng HuiChief Financial Officer · born 1987
- Mr. Ming King Chiu FCIS, FCSCompany Secretary · born 1977